pmc-enju-pas Home  

PMC:3359311 / 16297-17810 JSONTXT 14 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T5503 0-10 NN denotes Disruption
T5504 11-13 IN denotes of
T5505 14-18 NN denotes CFTR
T5506 19-27 NN denotes activity
T5507 28-32 VB denotes does
T5508 33-36 RB denotes not
T5509 37-45 VB denotes increase
T5510 46-51 NN denotes IL-1β
T5511 52-62 NN denotes production
T5512 63-65 IN denotes in
T5513 66-71 NN denotes PBMCs
T5514 72-75 CC denotes and
T5515 76-81 NN denotes THP-1
T5516 82-87 NN denotes cells
T5517 88-89 DT denotes A
T5518 90-98 JJ denotes previous
T5519 99-104 NN denotes study
T5520 105-108 VB denotes has
T5521 109-118 VB denotes indicated
T5522 119-120 DT denotes a
T5523 121-125 NN denotes role
T5524 126-129 IN denotes for
T5525 130-138 NN denotes chloride
T5526 139-142 NN denotes ion
T5527 143-156 NN denotes concentration
T5528 157-159 IN denotes in
T5529 160-171 NN denotes suppression
T5530 172-174 IN denotes of
T5531 175-180 NN denotes NLRP3
T5532 181-193 JJ denotes inflammasome
T5533 194-204 NN denotes activation
T5534 205-206 -LRB- denotes [
T5535 206-208 CD denotes 34
T5536 208-209 -RRB- denotes ]
T5537 211-213 TO denotes To
T5538 214-223 VB denotes determine
T5539 224-231 IN denotes whether
T5540 232-236 NN denotes CFTR
T5541 237-248 NN denotes dysfunction
T5542 249-255 VB denotes alters
T5543 256-261 NN denotes IL-1β
T5544 262-272 NN denotes production
T5545 272-273 -COMMA- denotes ,
T5546 274-279 NN denotes THP-1
T5547 280-285 NN denotes cells
T5548 286-289 CC denotes and
T5549 290-295 NN denotes PBMCs
T5550 296-300 IN denotes from
T5551 301-303 NN denotes CF
T5552 304-312 NN denotes patients
T5553 313-316 CC denotes and
T5554 317-324 JJ denotes healthy
T5555 325-333 NN denotes controls
T5556 334-338 VB denotes were
T5557 339-346 VB denotes treated
T5558 347-351 IN denotes with
T5559 352-355 DT denotes the
T5560 356-360 NN denotes CFTR
T5561 361-370 NN denotes inhibitor
T5562 370-371 -COMMA- denotes ,
T5563 372-382 NN denotes CFTRinh172
T5564 382-383 -COMMA- denotes ,
T5565 384-389 JJ denotes prior
T5566 390-392 TO denotes to
T5567 393-403 NN denotes simulation
T5568 404-408 IN denotes with
T5569 409-413 JJ denotes live
T5570 414-416 NNP denotes P.
T5571 417-427 NN denotes aeruginosa
T5572 429-438 NN denotes Treatment
T5573 439-443 IN denotes with
T5574 444-454 NN denotes CFTRinh172
T5575 455-458 VB denotes did
T5576 459-462 RB denotes not
T5577 463-468 VB denotes alter
T5578 469-474 NN denotes IL-1β
T5579 475-477 CC denotes or
T5580 478-482 NN denotes IL-8
T5581 483-493 NN denotes production
T5582 494-496 IN denotes in
T5583 497-504 JJ denotes control
T5584 505-513 NN denotes subjects
T5585 514-516 CC denotes or
T5586 517-519 NN denotes CF
T5587 520-528 NN denotes patients
T5588 529-530 -LRB- denotes (
T5589 530-534 NN denotes Fig.
T5590 535-539 NN denotes 8a–b
T5591 539-540 -RRB- denotes )
T5592 542-551 RB denotes Similarly
T5593 551-552 -COMMA- denotes ,
T5594 553-558 NN denotes IL-1β
T5595 559-569 NN denotes production
T5596 570-573 VB denotes was
T5597 574-577 RB denotes not
T5598 578-587 JJ denotes different
T5599 588-590 IN denotes in
T5600 591-607 JJ denotes monocyte-derived
T5601 608-619 NN denotes macrophages
T5602 620-622 CC denotes or
T5603 623-628 NN denotes THP-1
T5604 629-637 NN denotes reporter
T5605 638-643 NN denotes cells
T5606 644-651 VB denotes treated
T5607 652-656 IN denotes with
T5608 657-667 NN denotes CFTRinh172
T5609 668-669 -LRB- denotes (
T5610 669-673 NNP denotes Fig.
T5611 674-678 NNP denotes 8c–d
T5612 678-679 -RRB- denotes )
T5613 681-685 NN denotes IL-8
T5614 686-687 -LRB- denotes (
T5615 687-691 NN denotes Fig.
T5616 692-694 NN denotes 8e
T5617 694-695 -RRB- denotes )
T5618 696-699 CC denotes and
T5619 700-705 NN denotes NF-κB
T5620 706-714 NN denotes activity
T5621 715-716 -LRB- denotes (
T5622 716-720 NNP denotes Fig.
T5623 721-723 NN denotes 8f
T5624 723-724 -RRB- denotes )
T5625 725-729 VB denotes were
T5626 730-734 RB denotes also
T5627 735-744 JJ denotes unchanged
T5628 745-747 IN denotes in
T5629 748-766 JJ denotes CFTRinh172-treated
T5630 767-772 NN denotes THP-1
T5631 773-781 NN denotes reporter
T5632 782-787 NN denotes cells
T14674 833-843 NN denotes Disruption
T14675 844-846 IN denotes of
T14676 847-851 NN denotes CFTR
T14677 852-860 NN denotes activity
T14678 861-865 VB denotes does
T14679 866-869 RB denotes not
T14680 870-878 VB denotes increase
T14681 879-884 NN denotes IL-1β
T14682 885-895 NN denotes production
T14683 896-898 IN denotes in
T14684 899-904 NN denotes PBMCs
T14685 905-907 CC denotes or
T14686 908-919 NN denotes macrophages
T14687 921-926 NN denotes PBMCs
T14688 927-931 IN denotes from
T14689 932-934 NN denotes CF
T14690 935-943 NN denotes patients
T14691 944-945 -LRB- denotes (
T14692 945-951 NN denotes n = 15
T14693 951-952 -RRB- denotes )
T14694 953-956 CC denotes and
T14695 957-965 NN denotes controls
T14696 966-967 -LRB- denotes (
T14697 967-973 NN denotes n = 13
T14698 973-974 -RRB- denotes )
T14699 975-979 VB denotes were
T14700 980-987 VB denotes treated
T14701 988-992 IN denotes with
T14702 993-1003 NN denotes CFTRinh172
T14703 1004-1005 -LRB- denotes (
T14704 1005-1007 CD denotes 10
T14705 1008-1010 NN denotes µM
T14706 1010-1011 -RRB- denotes )
T14707 1012-1015 IN denotes for
T14708 1016-1018 CD denotes 18
T14709 1019-1024 NN denotes hours
T14710 1025-1030 RB denotes prior
T14711 1031-1033 TO denotes to
T14712 1034-1045 NN denotes stimulation
T14713 1046-1050 IN denotes with
T14714 1051-1055 JJ denotes live
T14715 1056-1060 NN denotes PAO1
T14716 1061-1062 -LRB- denotes (
T14717 1062-1069 NN denotes MOI = 1
T14718 1069-1070 -RRB- denotes )
T14719 1070-1071 -LRB- denotes .
T14720 1072-1073 NN denotes (
T14721 1073-1074 -RRB- denotes A
T14722 1074-1079 NN denotes ) IL-
T14723 1079-1082 CC denotes 1β
T14724 1082-1083 -LRB- denotes a
T14725 1083-1084 NN denotes n
T14726 1084-1085 -RRB- denotes d
T14727 1086-1090 NN denotes (B)
T14728 1090-1100 NN denotes IL-8 produ
T14729 1100-1103 VB denotes cti
T14730 1103-1111 VB denotes on was m
T14731 1111-1113 IN denotes ea
T14732 1113-1115 CD denotes su
T14733 1115-1121 NN denotes red at
T14734 1122-1123 -LRB- denotes 2
T14735 1123-1124 NN denotes 4
T14736 1125-1126 -RRB- denotes h
T14737 1126-1135 NN denotes ours. (C)
T14738 1136-1140 IN denotes Mono
T14739 1140-1148 NN denotes cytes fr
T14740 1148-1149 -LRB- denotes o
T14741 1149-1154 NN denotes m con
T14742 1154-1155 -RRB- denotes t
T14743 1155-1159 VB denotes rols
T14744 1160-1174 VB denotes (n = 3) were d
T14745 1174-1178 IN denotes iffe
T14746 1178-1189 NN denotes rentiated i
T14747 1206-1217 NN denotes Macrophages
T14748 1218-1222 VB denotes were
T14749 1223-1230 VB denotes treated
T14750 1231-1235 IN denotes with
T14751 1236-1246 NN denotes CFTRinh172
T14752 1246-1247 -COMMA- denotes ,
T14753 1248-1258 VB denotes stimulated
T14754 1259-1261 IN denotes as
T14755 1262-1265 IN denotes per
T14756 1266-1275 NN denotes monocytes
T14757 1275-1276 -COMMA- denotes ,
T14758 1277-1280 CC denotes and
T14759 1281-1289 VB denotes measured
T14760 1290-1293 IN denotes for
T14761 1294-1299 NN denotes IL-1β
T14762 1300-1310 NN denotes production
T14763 1311-1313 IN denotes at
T14764 1314-1316 CD denotes 24
T14765 1317-1322 NN denotes hours
T14766 1324-1329 NN denotes THP-1
T14767 1330-1338 NN denotes reporter
T14768 1339-1344 NN denotes cells
T14769 1345-1349 VB denotes were
T14770 1350-1357 VB denotes treated
T14771 1358-1362 IN denotes with
T14772 1363-1373 NN denotes CFTRinh172
T14773 1374-1376 CD denotes 24
T14774 1377-1382 NN denotes hours
T14775 1383-1388 RB denotes prior
T14776 1389-1391 TO denotes to
T14777 1392-1403 NN denotes stimulation
T14778 1404-1408 IN denotes with
T14779 1409-1413 NN denotes PAO1
T14780 1414-1417 CC denotes and
T14781 1418-1426 VB denotes measured
T14782 1427-1430 IN denotes for
T14783 1431-1432 -LRB- denotes (
T14784 1432-1433 NN denotes D
T14785 1433-1434 -RRB- denotes )
T14786 1435-1440 NN denotes IL-1β
T14787 1441-1450 NN denotes secretion
T14788 1450-1451 -COMMA- denotes ,
T14789 1452-1453 -LRB- denotes (
T14790 1453-1454 NN denotes E
T14791 1454-1455 -RRB- denotes )
T14792 1456-1460 NN denotes IL-8
T14793 1460-1461 -COMMA- denotes ,
T14794 1462-1465 CC denotes and
T14795 1466-1467 -LRB- denotes (
T14796 1467-1468 NN denotes F
T14797 1468-1469 -RRB- denotes )
T14798 1470-1480 NN denotes NF-κB/AP-1
T14799 1481-1489 NN denotes activity
T14800 1490-1492 IN denotes at
T14801 1493-1495 CD denotes 24
T14802 1496-1501 NN denotes hours
T14803 1502-1503 -LRB- denotes (
T14804 1503-1508 NN denotes n = 4
T14805 1508-1509 -RRB- denotes )
R13030 T14674 T14675 arg1Of Disruption,of
R13031 T14674 T14678 arg1Of Disruption,does
R13032 T14674 T14680 arg1Of Disruption,increase
R13033 T14677 T14675 arg2Of activity,of
R13034 T14677 T14676 arg1Of activity,CFTR
R13035 T14680 T14678 arg2Of increase,does
R13036 T14680 T14679 arg1Of increase,not
R13037 T14682 T14680 arg2Of production,increase
R13038 T14682 T14681 arg1Of production,IL-1β
R13039 T14682 T14683 arg1Of production,in
R13040 T14684 T14685 arg1Of PBMCs,or
R13041 T14685 T14683 arg2Of or,in
R13042 T14686 T14685 arg2Of macrophages,or
R13043 T14687 T14688 arg1Of PBMCs,from
R13044 T14687 T14699 arg1Of PBMCs,were
R13045 T14687 T14700 arg2Of PBMCs,treated
R13046 T14687 T14743 arg1Of PBMCs,rols
R13047 T14687 T14744 arg2Of PBMCs,(n = 3) were d
R13048 T14690 T14689 arg1Of patients,CF
R13049 T14690 T14691 arg1Of patients,(
R13050 T14690 T14694 arg1Of patients,and
R13051 T14692 T14691 arg2Of n = 15,(
R13052 T14693 T14691 arg3Of ),(
R13053 T14694 T14688 arg2Of and,from
R13054 T14695 T14694 arg2Of controls,and
R13055 T14695 T14696 arg1Of controls,(
R13056 T14697 T14696 arg2Of n = 13,(
R13057 T14698 T14696 arg3Of ),(
R13058 T14700 T14699 arg2Of treated,were
R13059 T14700 T14701 arg1Of treated,with
R13060 T14700 T14723 arg1Of treated,1β
R13061 T14702 T14701 arg2Of CFTRinh172,with
R13062 T14702 T14703 arg1Of CFTRinh172,(
R13063 T14702 T14707 arg1Of CFTRinh172,for
R13064 T14702 T14711 arg1Of CFTRinh172,to
R13065 T14705 T14703 arg2Of µM,(
R13066 T14705 T14704 arg1Of µM,10
R13067 T14706 T14703 arg3Of ),(
R13068 T14709 T14707 arg2Of hours,for
R13069 T14709 T14708 arg1Of hours,18
R13070 T14711 T14710 arg1Of to,prior
R13071 T14712 T14711 arg2Of stimulation,to
R13072 T14712 T14713 arg1Of stimulation,with
R13073 T14715 T14714 arg1Of PAO1,live
R13074 T14715 T14716 arg1Of PAO1,(
R13075 T14715 T14719 arg1Of PAO1,.
R13076 T14717 T14716 arg2Of MOI = 1,(
R13077 T14718 T14716 arg3Of ),(
R13078 T14720 T14719 arg2Of (,.
R13079 T14721 T14719 arg3Of A,.
R13080 T14722 T14713 arg2Of ) IL-,with
R13081 T14722 T14715 arg1Of ) IL-,PAO1
R13082 T14725 T14724 arg2Of n,a
R13083 T14726 T14724 arg3Of d,a
R13084 T14728 T14724 arg1Of IL-8 produ,a
R13085 T14728 T14727 arg1Of IL-8 produ,(B)
R13086 T14728 T14729 arg1Of IL-8 produ,cti
R13087 T14728 T14730 arg2Of IL-8 produ,on was m
R13088 T14730 T14729 arg2Of on was m,cti
R13089 T14730 T14731 arg1Of on was m,ea
R13090 T14735 T14734 arg2Of 4,2
R13091 T14736 T14734 arg3Of h,2
R13092 T14737 T14731 arg2Of ours. (C),ea
R13093 T14737 T14732 arg1Of ours. (C),su
R13094 T14737 T14733 arg1Of ours. (C),red at
R13095 T14737 T14734 arg1Of ours. (C),2
R13096 T14737 T14738 arg1Of ours. (C),Mono
R13097 T14739 T14738 arg2Of cytes fr,Mono
R13098 T14739 T14740 arg1Of cytes fr,o
R13099 T14741 T14740 arg2Of m con,o
R13100 T14742 T14740 arg3Of t,o
R13101 T14744 T14723 arg2Of (n = 3) were d,1β
R13102 T14744 T14729 modOf (n = 3) were d,cti
R13103 T14744 T14743 arg2Of (n = 3) were d,rols
R13104 T14744 T14745 arg1Of (n = 3) were d,iffe
R13105 T14746 T14745 arg2Of rentiated i,iffe
R13106 T14747 T14748 arg1Of Macrophages,were
R13107 T14747 T14749 arg2Of Macrophages,treated
R13108 T14749 T14748 arg2Of treated,were
R13109 T14749 T14750 arg1Of treated,with
R13110 T14751 T14750 arg2Of CFTRinh172,with
R13111 T14751 T14752 arg1Of CFTRinh172,","
R13112 T14751 T14753 arg2Of CFTRinh172,stimulated
R13113 T14751 T14759 arg2Of CFTRinh172,measured
R13114 T14753 T14755 arg1Of stimulated,per
R13115 T14753 T14758 arg1Of stimulated,and
R13116 T14755 T14754 arg1Of per,as
R13117 T14756 T14755 arg2Of monocytes,per
R13118 T14758 T14757 arg1Of and,","
R13119 T14759 T14758 arg2Of measured,and
R13120 T14759 T14760 arg1Of measured,for
R13121 T14759 T14763 arg1Of measured,at
R13122 T14762 T14760 arg2Of production,for
R13123 T14762 T14761 arg1Of production,IL-1β
R13124 T14765 T14763 arg2Of hours,at
R13125 T14765 T14764 arg1Of hours,24
R13126 T14768 T14766 arg1Of cells,THP-1
R13127 T14768 T14767 arg1Of cells,reporter
R13128 T14768 T14769 arg1Of cells,were
R13129 T14768 T14770 arg2Of cells,treated
R13130 T14768 T14781 arg2Of cells,measured
R13131 T14770 T14771 arg1Of treated,with
R13132 T14770 T14775 arg1Of treated,prior
R13133 T14770 T14780 arg1Of treated,and
R13134 T14772 T14771 arg2Of CFTRinh172,with
R13135 T14774 T14773 arg1Of hours,24
R13136 T14775 T14774 arg1Of prior,hours
R13137 T14775 T14776 arg1Of prior,to
R13138 T14777 T14776 arg2Of stimulation,to
R13139 T14777 T14778 arg1Of stimulation,with
R13140 T14779 T14778 arg2Of PAO1,with
R13141 T14780 T14769 arg2Of and,were
R13142 T14781 T14780 arg2Of measured,and
R13143 T14781 T14782 arg1Of measured,for
R13144 T14784 T14783 arg2Of D,(
R13145 T14785 T14783 arg3Of ),(
R13146 T14787 T14783 arg1Of secretion,(
R13147 T14787 T14786 arg1Of secretion,IL-1β
R13148 T14787 T14788 arg1Of secretion,","
R13149 T14788 T14794 arg1Of ",",and
R13150 T14790 T14789 arg2Of E,(
R13151 T14791 T14789 arg3Of ),(
R13152 T14792 T14788 arg2Of IL-8,","
R13153 T14792 T14789 arg1Of IL-8,(
R13154 T14794 T14782 arg2Of and,for
R13155 T14794 T14793 arg1Of and,","
R13156 T14796 T14795 arg2Of F,(
R13157 T14797 T14795 arg3Of ),(
R13158 T14799 T14794 arg2Of activity,and
R13159 T14799 T14795 arg1Of activity,(
R13160 T14799 T14798 arg1Of activity,NF-κB/AP-1
R13161 T14799 T14800 arg1Of activity,at
R13162 T14802 T14800 arg2Of hours,at
R13163 T14802 T14801 arg1Of hours,24
R13164 T14802 T14803 arg1Of hours,(
R13165 T14804 T14803 arg2Of n = 4,(
R13166 T14805 T14803 arg3Of ),(
R4753 T5503 T5504 arg1Of Disruption,of
R4754 T5503 T5507 arg1Of Disruption,does
R4755 T5503 T5509 arg1Of Disruption,increase
R4756 T5506 T5504 arg2Of activity,of
R4757 T5506 T5505 arg1Of activity,CFTR
R4758 T5509 T5507 arg2Of increase,does
R4759 T5509 T5508 arg1Of increase,not
R4760 T5511 T5509 arg2Of production,increase
R4761 T5511 T5510 arg1Of production,IL-1β
R4762 T5511 T5512 arg1Of production,in
R4763 T5513 T5514 arg1Of PBMCs,and
R4764 T5514 T5512 arg2Of and,in
R4765 T5516 T5514 arg2Of cells,and
R4766 T5516 T5515 arg1Of cells,THP-1
R4767 T5519 T5517 arg1Of study,A
R4768 T5519 T5518 arg1Of study,previous
R4769 T5519 T5520 arg1Of study,has
R4770 T5519 T5521 arg1Of study,indicated
R4771 T5521 T5520 arg2Of indicated,has
R4772 T5523 T5521 arg2Of role,indicated
R4773 T5523 T5522 arg1Of role,a
R4774 T5523 T5524 arg1Of role,for
R4775 T5523 T5528 arg1Of role,in
R4776 T5527 T5524 arg2Of concentration,for
R4777 T5527 T5525 arg1Of concentration,chloride
R4778 T5527 T5526 arg1Of concentration,ion
R4779 T5529 T5528 arg2Of suppression,in
R4780 T5529 T5530 arg1Of suppression,of
R4781 T5533 T5530 arg2Of activation,of
R4782 T5533 T5531 arg1Of activation,NLRP3
R4783 T5533 T5532 arg1Of activation,inflammasome
R4784 T5533 T5534 arg1Of activation,[
R4785 T5535 T5534 arg2Of 34,[
R4786 T5536 T5534 arg3Of ],[
R4787 T5538 T5537 arg1Of determine,To
R4788 T5541 T5540 arg1Of dysfunction,CFTR
R4789 T5541 T5542 arg1Of dysfunction,alters
R4790 T5542 T5538 arg2Of alters,determine
R4791 T5542 T5539 arg1Of alters,whether
R4792 T5544 T5542 arg2Of production,alters
R4793 T5544 T5543 arg1Of production,IL-1β
R4794 T5547 T5546 arg1Of cells,THP-1
R4795 T5547 T5548 arg1Of cells,and
R4796 T5548 T5556 arg1Of and,were
R4797 T5548 T5557 arg2Of and,treated
R4798 T5549 T5548 arg2Of PBMCs,and
R4799 T5549 T5550 arg1Of PBMCs,from
R4800 T5552 T5551 arg1Of patients,CF
R4801 T5552 T5553 arg1Of patients,and
R4802 T5553 T5550 arg2Of and,from
R4803 T5555 T5553 arg2Of controls,and
R4804 T5555 T5554 arg1Of controls,healthy
R4805 T5557 T5537 modOf treated,To
R4806 T5557 T5545 arg1Of treated,","
R4807 T5557 T5556 arg2Of treated,were
R4808 T5557 T5558 arg1Of treated,with
R4809 T5561 T5558 arg2Of inhibitor,with
R4810 T5561 T5559 arg1Of inhibitor,the
R4811 T5561 T5560 arg1Of inhibitor,CFTR
R4812 T5561 T5562 arg1Of inhibitor,","
R4813 T5563 T5562 arg2Of CFTRinh172,","
R4814 T5563 T5564 arg1Of CFTRinh172,","
R4815 T5563 T5565 arg1Of CFTRinh172,prior
R4816 T5565 T5566 arg1Of prior,to
R4817 T5567 T5566 arg2Of simulation,to
R4818 T5567 T5568 arg1Of simulation,with
R4819 T5571 T5568 arg2Of aeruginosa,with
R4820 T5571 T5569 arg1Of aeruginosa,live
R4821 T5571 T5570 arg1Of aeruginosa,P.
R4822 T5572 T5573 arg1Of Treatment,with
R4823 T5572 T5575 arg1Of Treatment,did
R4824 T5572 T5577 arg1Of Treatment,alter
R4825 T5574 T5573 arg2Of CFTRinh172,with
R4826 T5577 T5575 arg2Of alter,did
R4827 T5577 T5576 arg1Of alter,not
R4828 T5578 T5579 arg1Of IL-1β,or
R4829 T5580 T5579 arg2Of IL-8,or
R4830 T5581 T5578 arg1Of production,IL-1β
R4831 T5581 T5580 arg1Of production,IL-8
R4832 T5581 T5582 arg1Of production,in
R4833 T5581 T5585 arg1Of production,or
R4834 T5584 T5582 arg2Of subjects,in
R4835 T5584 T5583 arg1Of subjects,control
R4836 T5585 T5577 arg2Of or,alter
R4837 T5587 T5585 arg2Of patients,or
R4838 T5587 T5586 arg1Of patients,CF
R4839 T5587 T5588 arg1Of patients,(
R4840 T5590 T5588 arg2Of 8a–b,(
R4841 T5590 T5589 arg1Of 8a–b,Fig.
R4842 T5591 T5588 arg3Of ),(
R4843 T5595 T5594 arg1Of production,IL-1β
R4844 T5595 T5596 arg1Of production,was
R4845 T5595 T5598 arg1Of production,different
R4846 T5596 T5592 arg1Of was,Similarly
R4847 T5596 T5593 arg1Of was,","
R4848 T5596 T5597 arg1Of was,not
R4849 T5598 T5596 arg2Of different,was
R4850 T5598 T5599 arg1Of different,in
R4851 T5601 T5600 arg1Of macrophages,monocyte-derived
R4852 T5601 T5602 arg1Of macrophages,or
R4853 T5602 T5599 arg2Of or,in
R4854 T5602 T5606 arg2Of or,treated
R4855 T5605 T5602 arg2Of cells,or
R4856 T5605 T5603 arg1Of cells,THP-1
R4857 T5605 T5604 arg1Of cells,reporter
R4858 T5606 T5607 arg1Of treated,with
R4859 T5608 T5607 arg2Of CFTRinh172,with
R4860 T5608 T5609 arg1Of CFTRinh172,(
R4861 T5611 T5609 arg2Of 8c–d,(
R4862 T5611 T5610 arg1Of 8c–d,Fig.
R4863 T5612 T5609 arg3Of ),(
R4864 T5613 T5614 arg1Of IL-8,(
R4865 T5613 T5618 arg1Of IL-8,and
R4866 T5616 T5614 arg2Of 8e,(
R4867 T5616 T5615 arg1Of 8e,Fig.
R4868 T5617 T5614 arg3Of ),(
R4869 T5618 T5625 arg1Of and,were
R4870 T5618 T5627 arg1Of and,unchanged
R4871 T5620 T5618 arg2Of activity,and
R4872 T5620 T5619 arg1Of activity,NF-κB
R4873 T5620 T5621 arg1Of activity,(
R4874 T5623 T5621 arg2Of 8f,(
R4875 T5623 T5622 arg1Of 8f,Fig.
R4876 T5624 T5621 arg3Of ),(
R4877 T5625 T5626 arg1Of were,also
R4878 T5627 T5625 arg2Of unchanged,were
R4879 T5627 T5628 arg1Of unchanged,in
R4880 T5632 T5628 arg2Of cells,in
R4881 T5632 T5629 arg1Of cells,CFTRinh172-treated
R4882 T5632 T5630 arg1Of cells,THP-1
R4883 T5632 T5631 arg1Of cells,reporter